Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Stem Cell Research

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 80 articles: HTML format

Single Articles

July 2022
1. DHANYAMRAJU PK, Schell TD, Amin S, Robertson GP, et al
   Drug-Tolerant Persister Cells in Cancer Therapy Resistance.
   Cancer Res. 2022;82:2503-2514.
   PubMed     Abstract available
   
   
   
2. LI D, Zhang Q, Li L, Chen K, et al
   beta2-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages.
   Cancer Res. 2022 Jul 15. pii: 707040. doi: 10.1158/0008-5472.CAN-22-0507.
   PubMed     Abstract available
   
   
   May 2022
3. HEINZ MC, Peters NA, Oost KC, Lindeboom RGH, et al
   Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage.
   Cancer Res. 2022;82:1953-1968.
   PubMed     Abstract available
   
   
   
4. LEBLEU VS
   Plasticity Enables Cooperation among Heterogeneous Cancer Cell Populations to Support Metastatic Fitness.
   Cancer Res. 2022;82:1870-1871.
   PubMed     Abstract available
   
   
   April 2022
5. WANG H, Xu H, Chen W, Cheng M, et al
   Rab13 sustains breast cancer stem cells by supporting tumor-stroma crosstalk.
   Cancer Res. 2022 Apr 8. pii: 694330. doi: 10.1158/0008-5472.CAN-21-4097.
   PubMed     Abstract available
   
   
   March 2022
6. SAMANTA D, Park Y, Andrabi SA, Shelton LM, et al
   Correction: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.
   Cancer Res. 2022;82:1153.
   PubMed    
   
   
   
7. OSBORNE JK, Minna JD
   Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications.
   Cancer Res. 2022;82:972-973.
   PubMed     Abstract available
   
   
   February 2022
8. AUZMENDI-IRIARTE J, Otaegi-Ugartemendia M, Carrasco-Garcia E, Azkargorta M, et al
   Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity.
   Cancer Res. 2022 Feb 7. pii: 0008-5472.CAN-21-2161.
   PubMed     Abstract available
   
   
   January 2022
9. YIN H, Jing B, Xu D, Guo W, et al
   Identification of Active Bronchioalveolar Stem Cells as the Cell-of-Origin in Lung Adenocarcinoma.
   Cancer Res. 2022 Jan 19. pii: 0008-5472.CAN-21-2445.
   PubMed     Abstract available
   
   
   November 2021
10. JUNG Y, Cackowski FC, Yumoto K, Decker AM, et al
    Correction: CXCL12gamma Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.
    Cancer Res. 2021;81:5777.
    PubMed    
    
    
    
11. BERLIN C, Cottard F, Willmann D, Urban S, et al
    KMT9 controls stemness and growth of colorectal cancer.
    Cancer Res. 2021 Nov 4. pii: 0008-5472.CAN-21-1261.
    PubMed     Abstract available
    
    
    October 2021
12. FISHER ML, Balinth S, Hwangbo Y, Wu C, et al
    BRD4 REGULATES TRANSCRIPTION FACTOR Np63alphaTO DRIVE A CANCER STEM CELL PHENOTYPE IN SQUAMOUS CELL CARCINOMAS.
    Cancer Res. 2021 Oct 25. pii: 0008-5472.CAN-21-0707.
    PubMed     Abstract available
    
    
    
13. GOLDBERG L, Negi V, Chung YJ, Onozawa M, et al
    Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL.
    Cancer Res. 2021;81:5033-5046.
    PubMed     Abstract available
    
    
    September 2021
14. SANJIV K, Calderon-Montano JM, Pham TM, Erkers T, et al
    MTH1 inhibitor TH1579 induces oxidative DNA damage and mitotic arrest in acute myeloid leukemia.
    Cancer Res. 2021 Sep 30. pii: 0008-5472.CAN-21-0061.
    PubMed     Abstract available
    
    
    
15. LIU C, Qiang J, Deng Q, Xia J, et al
    ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression.
    Cancer Res. 2021 Sep 27. pii: 0008-5472.CAN-21-1337.
    PubMed     Abstract available
    
    
    
16. LOH JJ, Li TW, Zhou L, Wong TL, et al
    FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness.
    Cancer Res. 2021 Sep 22. pii: 0008-5472.CAN-20-4226.
    PubMed     Abstract available
    
    
    
17. YANG L, Sun J, Li M, Long Y, et al
    Oxidized low-density lipoprotein links hypercholesterolemia and bladder cancer aggressiveness by promoting cancer stemness.
    Cancer Res. 2021 Sep 3. pii: 0008-5472.CAN-21-0646.
    PubMed     Abstract available
    
    
    August 2021
18. LIU J, Rebecca VW, Kossenkov AV, Connelly T, et al
    Neural crest-like stem cell transcriptome analysis identifies LPAR1 in melanoma progression and therapy resistance.
    Cancer Res. 2021 Aug 30. pii: 0008-5472.CAN-20-1496.
    PubMed     Abstract available
    
    
    
19. DUTTA A, Nath D, Yang Y, Le BT, et al
    CDK6 Is a Therapeutic Target in Myelofibrosis.
    Cancer Res. 2021;81:4332-4345.
    PubMed     Abstract available
    
    
    
20. WANG X, Chen Y, Wang X, Tian H, et al
    Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11.
    Cancer Res. 2021 Aug 12. pii: 0008-5472.CAN-21-0567.
    PubMed     Abstract available
    
    
    
21. SOLE A, Grossetete S, Heintze M, Babin L, et al
    Unraveling Ewing sarcoma tumorigenesis originating from patient-derived Mesenchymal Stem Cells.
    Cancer Res. 2021 Aug 2. pii: 0008-5472.CAN-20-3837.
    PubMed     Abstract available
    
    
    July 2021
22. MAIFREDE S, Le BV, Nieborowska-Skorska M, Golovine K, et al
    TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.
    Cancer Res. 2021 Jul 2. pii: 0008-5472.CAN-20-3761.
    PubMed     Abstract available
    
    
    June 2021
23. CANO A, Lopez-Menendez C, Vazquez-Naharro A, Santos V, et al
    E2A modulates stemness, metastasis, and therapeutic resistance of breast cancer.
    Cancer Res. 2021 Jun 18. pii: 0008-5472.CAN-20-2685.
    PubMed     Abstract available
    
    
    
24. CIERI N, Maurer K, Wu CJ
    60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer Immunotherapy.
    Cancer Res. 2021 Jun 9. pii: 0008-5472.CAN-21-0301.
    PubMed     Abstract available
    
    
    May 2021
25. MILLER SA, Policastro RA, Sriramkumar S, Lai T, et al
    LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF mutant colorectal cancer.
    Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-3562.
    PubMed     Abstract available
    
    
    
26. BOMMI PV, Bowen CM, Reyes-Uribe L, Wu W, et al
    The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.
    Cancer Res. 2021;81:2760-2773.
    PubMed     Abstract available
    
    
    
27. WANG X, Jia Y, Wen L, Mu W, et al
    Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome.
    Cancer Res. 2021;81:2745-2759.
    PubMed     Abstract available
    
    
    
28. FRAU C, Jamard C, Delpouve G, Guardia GDA, et al
    Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.
    Cancer Res. 2021;81:2730-2744.
    PubMed     Abstract available
    
    
    
29. LI Y, Wang M, Yang M, Xiao Y, et al
    Nicotine-induced ILF2 facilitates nuclear mRNA export of pluripotency factors to promote stemness and chemoresistance in human esophageal cancer.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-4160.
    PubMed     Abstract available
    
    
    
30. DENG X, Tchieu J, Higginson DS, Hsu KS, et al
    Disabling the Fanconi Anemia Pathway in Stem Cells Leads to Radioresistance and Genomic Instability.
    Cancer Res. 2021 May 3. pii: 0008-5472.CAN-20-3309.
    PubMed     Abstract available
    
    
    
31. MA T, Hu C, Lal B, Zhou W, et al
    Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells.
    Cancer Res. 2021;81:2457-2469.
    PubMed     Abstract available
    
    
    
32. LO CH, Shay G, McGuire JJ, Li T, et al
    Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall Survival.
    Cancer Res. 2021;81:2415-2428.
    PubMed     Abstract available
    
    
    April 2021
33. LEUNG HW, Leung CO, Lau EY, Chung KPS, et al
    EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-21-0184.
    PubMed     Abstract available
    
    
    
34. ALVAREZ-TROTTA A, Guerrant W, Astudillo L, Lahiry M, et al
    Pharmacological disruption of the Notch1 transcriptional complex inhibits tumor growth by selectively targeting cancer stem cells.
    Cancer Res. 2021 Apr 5. pii: 0008-5472.CAN-20-3611.
    PubMed     Abstract available
    
    
    March 2021
35. SILVERMAN DA, Martinez VK, Dougherty PM, Myers JN, et al
    Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.
    Cancer Res. 2021;81:1431-1440.
    PubMed     Abstract available
    
    
    February 2021
36. UNNO K, Chalmers ZR, Pamarthy S, Vatapalli R, et al
    Activated ALK Cooperates with N-Myc via Wnt/beta-catenin Signaling to Induce Neuroendocrine Prostate Cancer.
    Cancer Res. 2021 Feb 26. pii: 0008-5472.CAN-20-3351.
    PubMed     Abstract available
    
    
    
37. MENG Y, Zhao Q, An L, Jiao S, et al
    A TNFR2-hnRNPK axis promotes primary liver cancer development via activation of YAP signaling in hepatic progenitor cells.
    Cancer Res. 2021 Feb 22. pii: 0008-5472.CAN-20-3175.
    PubMed     Abstract available
    
    
    
38. BI L, Ren Y, Feng M, Meng P, et al
    HDAC11 regulates glycolysis through the LKB1/AMPK signaling pathway to maintain hepatocellular carcinoma stemness.
    Cancer Res. 2021 Feb 18. pii: 0008-5472.CAN-20-3044.
    PubMed     Abstract available
    
    
    
39. BELUR NAGARAJ A, Knarr M, Sekhar S, Connor RS, et al
    The miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer.
    Cancer Res. 2021 Feb 11. pii: 0008-5472.CAN-20-2041.
    PubMed     Abstract available
    
    
    
40. QUINN HM, Vogel R, Popp O, Mertins P, et al
    YAP and beta-catenin cooperate to drive oncogenesis in basal breast cancer.
    Cancer Res. 2021 Feb 11. pii: 0008-5472.CAN-20-2801.
    PubMed     Abstract available
    
    
    
41. SUTCLIFFE MD, Galvao RP, Wang L, Kim J, et al
    Premalignant oligodendrocyte precursor cells stall in a heterogeneous state of replication stress prior to gliomagenesis.
    Cancer Res. 2021 Feb 2. pii: 0008-5472.CAN-20-1037.
    PubMed     Abstract available
    
    
    
42. PARDINI B, Dragomir MP
    SCIRT lncRNA Blocks the Shot of Breast Cancer Cells Self-Renewal Mechanism.
    Cancer Res. 2021;81:535-536.
    PubMed     Abstract available
    
    
    January 2021
43. SANDIFORD OA, Donnelly RJ, El-Far M, Burgmeyer LM, et al
    Mesenchymal stem cell-secreted extracellular vesicles instruct stepwise dedifferentiation of breast cancer cells into dormancy at the bone marrow perivascular region.
    Cancer Res. 2021 Jan 26. pii: 0008-5472.CAN-20-2434.
    PubMed     Abstract available
    
    
    
44. BERG TJ, Marques C, Pantazopoulou V, Johansson E, et al
    The irradiated brain microenvironment supports glioma stemness and survival via astrocyte-derived Transglutaminase 2.
    Cancer Res. 2021 Jan 22. pii: 0008-5472.CAN-20-1785.
    PubMed     Abstract available
    
    
    
45. NEY GM, Yang KB, Ng V, Liu L, et al
    Oncogenic N-Ras mitigates oxidative stress-induced apoptosis of hematopoietic stem cells.
    Cancer Res. 2021 Jan 13. pii: 0008-5472.CAN-20-0118.
    PubMed     Abstract available
    
    
    
46. TAMIRO F, Weng AP, Giambra V
    Targeting leukemia-initiating cells in acute lymphoblastic leukemia (ALL).
    Cancer Res. 2021 Jan 7. pii: 0008-5472.CAN-20-2571.
    PubMed     Abstract available
    
    
    
47. GANGULY K, Krishn SR, Rachagani S, Jahan R, et al
    Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
    Cancer Res. 2021;81:91-102.
    PubMed     Abstract available
    
    
    
48. STEENBRUGGE J, De Jaeghere EA, Meyer E, Denys H, et al
    Splenic Hematopoietic and Stromal Cells in Cancer Progression.
    Cancer Res. 2021;81:27-34.
    PubMed     Abstract available
    
    
    December 2020
49. HAGIWARA M, Yasumizu Y, Yamashita N, Rajabi H, et al
    MUC1-C ACTIVATES THE BAF (mSWI/SNF) COMPLEX IN PROSTATE CANCER STEM CELLS.
    Cancer Res. 2020 Dec 15. pii: 0008-5472.CAN-20-2588.
    PubMed     Abstract available
    
    
    
50. TORTI SV, Torti FM
    Iron and Cancer: 2020 Vision.
    Cancer Res. 2020;80:5435-5448.
    PubMed     Abstract available
    
    
    
51. ORAVECZ-WILSON K, Rossi C, Zajac C, Sun Y, et al
    ATG5-dependent autophagy uncouples T cell proliferative and effector functions and separates graft-versus-host disease from graft-versus-leukemia.
    Cancer Res. 2020 Dec 4. pii: 0008-5472.CAN-20-1346.
    PubMed     Abstract available
    
    
    November 2020
52. WANG Y, Zhao G, Condello S, Huang H, et al
    Frizzled-7 Identifies Platinum Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
    Cancer Res. 2020 Nov 10. pii: 0008-5472.CAN-20-1488.
    PubMed     Abstract available
    
    
    
53. TAGAL V, Roth MG
    Loss of Aurora kinase signaling allows lung cancer cells to adopt endoreplication and form polyploid giant cancer cells that resist antimitotic drugs.
    Cancer Res. 2020 Nov 10. pii: 0008-5472.CAN-20-1693.
    PubMed     Abstract available
    
    
    
54. LI J, Liao T, Liu H, Yuan H, et al
    Hypoxic glioma stem cell-derived exosomes containing Linc01060 promote progression of glioma by regulating the MZF1/c-Myc/HIF-1alpha.
    Cancer Res. 2020 Nov 6. pii: 0008-5472.CAN-20-2270.
    PubMed     Abstract available
    
    
    October 2020
55. RESTALL IJ, Cseh O, Richards LM, Pugh TJ, et al
    Brain tumor stem cell dependence on glutaminase reveals a metabolic vulnerability through the amino acid deprivation response pathway.
    Cancer Res. 2020 Oct 26. pii: 0008-5472.CAN-19-3923.
    PubMed     Abstract available
    
    
    
56. CHAMBERLIN T, Clack M, Silvers C, Kuziel G, et al
    Targeting Obesity-Induced Macrophages during Preneoplastic Growth Promotes Mammary Epithelial Stem/Progenitor Activity, DNA Damage, and Tumor Formation.
    Cancer Res. 2020;80:4465-4475.
    PubMed     Abstract available
    
    
    
57. WANG TW, Chern E, Hsu CW, Tseng KC, et al
    SIRT1-mediated expression of CD24 and epigenetic suppression of novel tumor suppressor miR-1185-1 increases colorectal cancer stemness.
    Cancer Res. 2020 Oct 12. pii: 0008-5472.CAN-19-3188.
    PubMed     Abstract available
    
    
    
58. LEAVITT RJ, Acharya MM, Baulch JE, Limoli CL, et al
    Extracellular Vesicle-Derived miR-124 Resolves Radiation-Induced Brain Injury.
    Cancer Res. 2020;80:4266-4277.
    PubMed     Abstract available
    
    
    September 2020
59. STIEHL T, Wang W, Lutz C, Marciniak-Czochra A, et al
    Mathematical Modeling Provides Evidence for Niche Competition in Human AML and Serves as a Tool to Improve Risk Stratification.
    Cancer Res. 2020;80:3983-3992.
    PubMed     Abstract available
    
    
    
60. BHAT-NAKSHATRI P, Kumar B, Simpson E, Ludwig KK, et al
    Breast cancer cell detection and characterization from breast milk-derived cells.
    Cancer Res. 2020 Sep 15. pii: 0008-5472.CAN-20-1030.
    PubMed     Abstract available
    
    
    
61. VOSS DM, Sloan A, Spina R, Ames HM, et al
    The Alternative Splicing Factor MBNL1 Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.
    Cancer Res. 2020 Sep 14. pii: 0008-5472.CAN-20-1233.
    PubMed     Abstract available
    
    
    August 2020
62. KONCAR RF, Agnihotri S
    Anarchy or Respect the Hierarchy? The Complexity of Glioblastoma.
    Cancer Res. 2020;80:3195-3196.
    PubMed     Abstract available
    
    
    
63. ALMAIRAC F, Turchi L, Sakakini N, Debruyne DN, et al
    ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a "Toggle Switch" of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells.
    Cancer Res. 2020;80:3236-3250.
    PubMed     Abstract available
    
    
    
64. LI Y, Zhang X, Zhu S, Dejene EA, et al
    HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma.
    Cancer Res. 2020;80:3265-3278.
    PubMed     Abstract available
    
    
    
65. AMBROSONE CB, Higgins MJ
    Relationships between breast feeding and breast cancer subtypes: lessons learned from studies in humans and in mice.
    Cancer Res. 2020 Aug 14. pii: 0008-5472.CAN-20-0077.
    PubMed     Abstract available
    
    
    July 2020
66. DATTILO R, Mottini C, Camera E, Lamolinara A, et al
    Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism.
    Cancer Res. 2020 Jul 23. pii: 0008-5472.CAN-19-1184.
    PubMed     Abstract available
    
    
    June 2020
67. YOKOMIZO-NAKANO T, Kubota S, Bai J, Hamashima A, et al
    Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.
    Cancer Res. 2020;80:2523-2536.
    PubMed     Abstract available
    
    
    
68. CHEN Y, Wang T, Huang M, Liu Q, et al
    MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Cancer Res. 2020;80:2472-2483.
    PubMed     Abstract available
    
    
    May 2020
69. CHEN J, Mitra A, Li S, Song S, et al
    Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFbeta Signaling.
    Cancer Res. 2020;80:1819-1832.
    PubMed     Abstract available
    
    
    April 2020
70. LOPEZ-BERTONI H, Kotchetkov IS, Mihelson N, Lal B, et al
    A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
    Cancer Res. 2020;80:1644-1655.
    PubMed     Abstract available
    
    
    
71. LIU X, Hu M, Liu P, Jiao M, et al
    ATM Paradoxically Promotes Oncogenic Transformation via Transcriptional Reprogramming.
    Cancer Res. 2020;80:1669-1680.
    PubMed     Abstract available
    
    
    
72. MEULEMANS L, Mesman RLS, Caputo SM, Krieger S, et al
    Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12.
    Cancer Res. 2020;80:1374-1386.
    PubMed     Abstract available
    
    
    
73. CHANDRA A, Jahangiri A, Chen W, Nguyen AT, et al
    Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
    Cancer Res. 2020;80:1498-1511.
    PubMed     Abstract available
    
    
    
74. ANDERSSON N, Bakker B, Karlsson J, Valind A, et al
    Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.
    Cancer Res. 2020;80:1512-1523.
    PubMed     Abstract available
    
    
    March 2020
75. ZHAO Y, Kaushik N, Kang JH, Kaushik NK, et al
    A Feedback loop comprising EGF/TGF-alpha Sustains TFCP2-mediated Breast Cancer Progression.
    Cancer Res. 2020 Mar 19. pii: 0008-5472.CAN-19-2908.
    PubMed     Abstract available
    
    
    
76. SAMI E, Paul BT, Koziol JA, ElShamy WM, et al
    The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.
    Cancer Res. 2020;80:1102-1117.
    PubMed     Abstract available
    
    
    February 2020
77. CHA HR, Lee JH, Ponnazhagan S
    Revisiting Immunotherapy: A Focus on Prostate Cancer.
    Cancer Res. 2020 Feb 17. pii: 0008-5472.CAN-19-2948.
    PubMed     Abstract available
    
    
    
78. NAZARI F, Oklejas AE, Nor JE, Pearson AT, et al
    In silico models accurately predict in vivo response for IL-6 blockade in head and neck cancer.
    Cancer Res. 2020 Feb 10. pii: 0008-5472.CAN-19-1846.
    PubMed     Abstract available
    
    
    
79. HEBERT JD, Myers SA, Naba A, Abbruzzese G, et al
    Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches.
    Cancer Res. 2020 Feb 4. pii: 0008-5472.CAN-19-2961.
    PubMed     Abstract available
    
    
    
80. GRAMANTIERI L, Pollutri D, Gagliardi M, Giovannini C, et al
    MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2020 Feb 3. pii: 0008-5472.CAN-19-0472.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: